The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
liposomal tretinoin
An intravenous formulation of tretinoin (vitamin A acid or all-trans retinoic acid) encased in liposomes. Tretinoin is a naturally occurring retinoic acid agent that binds to and activates retinoic acid receptors (RAR), effecting changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of carcinogenesis. This agent also inhibits telomerase, leading to telomere shortening and eventual apoptosis of certain tumor cell types. Liposome encapsulation extends the half-life of intravenously administered tretinoin. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | All-trans-retinoic acid liposomal tretinoin liposomal tretinoin liposome tretinoinLF | |
| |||
| US brand name: | | Atragen | |
| |||
| Abbreviation: | | L-ATRA | |
| |||
| Code name: | | AR-623 | |
| |||
